Therapeutic Instrumental Music Performance With Sensory-Enhanced Motor Imagery in Chronic Post-Stroke Rehabilitation

Sponsor
University of Toronto (Other)
Overall Status
Completed
CT.gov ID
NCT03246217
Collaborator
(none)
30
1
3
25.5
1.2

Study Details

Study Description

Brief Summary

Research has shown that music engages the brain bilaterally throughout cortical and subcortical regions, accessing extended sensorimotor, cognitive and affective networks. This research explores the hypothesis that use of these shared neural networks allows neurologic music therapy interventions targeting upper extremity motor control to promote plasticity and functional improvements in persons recovering from a cerebrovascular accident. The potential therapeutic benefits of these interventions on attentional processes and affective responding will also be examined.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Therapeutic Instrumental Music Performance
  • Behavioral: Therapeutic Performance with Sensory-Enhanced Motor Imagery
  • Behavioral: Therapeutic Performance with Motor Imagery
N/A

Detailed Description

More individuals are surviving and living with the effects of stroke, a trend that is expected to continue. Upper extremity limitations present a common, persistent challenge for stroke survivors, impacting quality of life. In addition, links have been found between physical impairment and depression, and depression and stroke-induced cognitive impairment. Music has been shown to exert multimodal effects on individuals and may be used as a mediating stimulus to promote therapeutic change. Furthermore, motor imagery may enhance the effectiveness of upper extremity interventions by engaging the same brain areas that are active in physical movement. The purpose of this study is to investigate the effects of therapeutic instrumental music performance and sensory-enhanced motor imagery on upper limb movement, affect and cognition following a stroke. Participants will be assessed at two baselines, and randomly assigned to one of three intervention groups: therapeutic instrumental music performance, therapeutic instrumental music performance and sensory-enhanced motor imagery, or therapeutic instrumental music performance and motor imagery without sensory enhancement.

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Efficacy of Therapeutic Instrumental Music Performance With Sensory-Enhanced Motor Imagery in Improving Therapeutic Outcomes for Individuals With Chronic Post-Stroke Hemiparesis
Actual Study Start Date :
Jul 20, 2017
Actual Primary Completion Date :
Sep 5, 2019
Actual Study Completion Date :
Sep 5, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Therapeutic Instrumental Music Performance

Therapeutic Instrumental Music Performance is a Neurologic Music Therapy technique in which selection of instruments, spatial configurations and sequences for playing are designed to facilitate retraining of movement patterns used in everyday life. Participants will receive nine individual forty-five minute sessions of Therapeutic Instrumental Music Performance, three sessions per week.

Behavioral: Therapeutic Instrumental Music Performance
Participants will play a variety of instruments (acoustic and electronic) to facilitate retraining of everyday functional movements.

Experimental: Therapeutic Performance with Sensory-Enhanced Motor Imagery

Participants will receive nine individual sessions, three times per week: thirty minutes of Therapeutic Instrumental Music Performance, followed by fifteen minutes of sensory-enhanced motor imagery. During sensory-enhanced motor imagery, participants will listen to a metronome set to their preferred pace for previously practised movements while engaging in motor imagery.

Behavioral: Therapeutic Instrumental Music Performance
Participants will play a variety of instruments (acoustic and electronic) to facilitate retraining of everyday functional movements.

Behavioral: Therapeutic Performance with Sensory-Enhanced Motor Imagery
Participants will listen to a metronome set to their preferred pace for previously practised movements while engaging in motor imagery.

Experimental: Therapeutic Performance with Motor Imagery

Participants will receive nine individual sessions, three times per week: thirty minutes of Therapeutic Instrumental Music Performance, followed by fifteen minutes of motor imagery. Motor imagery will involve mental practice of previous movement exercises.

Behavioral: Therapeutic Instrumental Music Performance
Participants will play a variety of instruments (acoustic and electronic) to facilitate retraining of everyday functional movements.

Behavioral: Therapeutic Performance with Motor Imagery
Participants will engage in motor imagery of previously practised movements.

Outcome Measures

Primary Outcome Measures

  1. Changes from baseline in Wolf Motor Function Test [Baseline 1, Baseline 2 (1 week later), Post intervention of 4 weeks]

    Measures upper extremity motor ability through timed and functional tasks.

  2. Changes from baseline in Fugl-Meyer Assessment Upper Extremity [Baseline 1, Baseline 2 (1 week later), Post intervention of 4 weeks]

    Performance based measure assessing motor capacity.

Secondary Outcome Measures

  1. Motor Activity Log [Baseline 1, Baseline 2 (1 week later), Post intervention of 4 weeks]

    Individuals rate quality and amount of movement during daily functional tasks.

  2. Trunk Impairment Scale [Baseline 1, Baseline 2 (1 week later), Post intervention of 4 weeks]

    Assessment of upper trunk impairment using the upper trunk items of the Trunk Impairment Scale

  3. Multiple Affect Adjective Check List-Revised [Baseline 1, Baseline 2 (1 week later), Post intervention of 4 weeks]

    Measure of affective state

  4. General Self-Efficacy Scale [Baseline 1, Baseline 2 (1 week later), Post intervention of 4 weeks]

    Assessment of perceived self-efficacy

  5. Digit Span [Baseline 1, Baseline 2 (1 week later), Post intervention of 4 weeks]

    Assesses working memory and attention

  6. Trail Making Test Part B [Baseline 1, Baseline 2 (1 week later), Post intervention of 4 weeks]

    Assesses mental flexibility and processing speed

Eligibility Criteria

Criteria

Ages Eligible for Study:
30 Years to 79 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • hemiparesis following a unilateral stroke (hemorrhagic or ischemic), sustained more than 6 months prior, with at least minimal volitional movement of the affected limb

  • permission from a physician to participate in an upper extremity rehabilitation program, including confirmation that the following disorders are not present: rheumatoid arthritis, upper extremity fracture, apraxia, neuropathy, somatosensory impairment

  • adequate language comprehension and neurocognitive function to understand and follow simple instructions

Exclusion Criteria:
  • currently enrolled in an upper extremity rehabilitation program or another upper extremity study

  • comorbid neurological disorder (e.g. multiple sclerosis, Parkinson's disease)

  • evidence of perceptual or cognitive impairment; e.g., unilateral spatial neglect, significant hearing impairment, Montreal Cognitive Assessment score of 25 or less

  • presence of aphasia

  • injections for spasticity within three months of participation

Contacts and Locations

Locations

Site City State Country Postal Code
1 Faculty of Music, University of Toronto Toronto Ontario Canada M5S2C5

Sponsors and Collaborators

  • University of Toronto

Investigators

  • Principal Investigator: Michael Thaut, PhD, University of Toronto

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Catherine Haire, PhD Candidate, University of Toronto
ClinicalTrials.gov Identifier:
NCT03246217
Other Study ID Numbers:
  • #34521
First Posted:
Aug 11, 2017
Last Update Posted:
Sep 16, 2019
Last Verified:
Sep 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 16, 2019